Echogenic glycol chitosan nanoparticles for ultrasound-triggered cancer theranostics

Theranostics

Volumn 5, Issue 12, 2015, Pages 1402-1418

  Min, Hyun Su ^a   You, Dong Gil ^a,b   Son, Sejin ^a   Jeon, Sangmin ^a,b   Park, Jae Hyung ^b   Lee, Seulki ^c   Kwon, Ick Chan ^a,d   Kim, Kwangmeyung ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Korea University   (South Korea)

Author keywords

Drug delivery; Echogenicity; Theranostic nanoparticle; Tumor targeting; Ultrasound contrast agent; Ultrasound imaging

Indexed keywords

CHITOSAN NANOPARTICLE; DOCETAXEL; DOXORUBICIN; GLYCOL; NANOMATERIAL; PERFLUOROPENTANE; POLYMER; CHITOSAN; GLYCOL-CHITOSAN; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; CELL VIABILITY; CHEMICAL STRUCTURE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ECHOGRAPHY; HUMAN; HUMAN CELL; HYDROPHILICITY; MALE; MALIGNANT NEOPLASTIC DISEASE; MICROBUBBLE; MOUSE; MTT ASSAY; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; TEMPERATURE; THERANOSTIC NANOMEDICINE; TREATMENT RESPONSE; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; DIAGNOSTIC IMAGING; DISEASE MODEL; METABOLISM; NEOPLASMS; PROCEDURES;

ANIMALS; CHITOSAN; DISEASE MODELS, ANIMAL; MALE; MICE, INBRED BALB C; MICE, INBRED C3H; NANOPARTICLES; NEOPLASMS; THERANOSTIC NANOMEDICINE; ULTRASONOGRAPHY;

EID: 84954214760     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.13099     Document Type: Article

References (34)

1. Rim HP, Min KH, Lee HJ, Jeong SY, Lee SC. pH-Tunable calcium phosphate covered mesoporous silica nanocontainers for intracellular controlled release of guest drugs. Angewandte Chemie. 2011; 50: 8853-7.
2. Son S, Kim WJ. Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery. Biomaterials. 2010; 31: 133-43.
3. Son S, Namgung R, Kim J, Singha K, Kim WJ. Bioreducible polymers for gene silencing and delivery. Accounts of chemical research. 2012; 45: 1100-12.
4. Cheng Z, Al Zaki A, Hui JZ, Muzykantov VR, Tsourkas A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science. 2012; 338: 903-10.
5. Son S, Singha K, Kim WJ. Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrier. Biomaterials. 2010; 31: 6344-54.
6. Lao J, Madani J, Puertolas T, Alvarez M, Hernandez A, Pazo-Cid R, et al. Liposomal Doxorubicin in the treatment of breast cancer patients: a review. Journal of drug delivery. 2013; 2013: 456409.
7. Reynolds JG, Geretti E, Hendriks BS, Lee H, Leonard SC, Klinz SG, et al. HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity. Toxicol Appl Pharm. 2012; 262: 1-10.
8. Hernot S, Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliver Rev. 2008; 60: 1153-66.
9. Sanna V, Pintus G, Bandiera P, Anedda R, Punzoni S, Sanna B, et al. Development of Polymeric Microbubbles Targeted to Prostate-Specific Membrane Antigen as Prototype of Novel Ultrasound Contrast Agents. Mol Pharmaceut. 2011; 8: 748-57.
10. Borden MA, Zhang H, Gillies RJ, Dayton PA, Ferrara KW. A stimulus-responsive contrast agent for ultrasound molecular imaging. Biomaterials. 2008; 29: 597-606.
11. Mayer CR, Geis NA, Katus HA, Bekeredjian R. Ultrasound targeted microbubble destruction for drug and gene delivery. Expert opinion on drug delivery. 2008; 5: 1121-38.
12. Mitragotri S. Innovation-Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov. 2005; 4: 255-60.
13. Miller DL, Smith NB, Bailey MR, Czarnota GJ, Hynynen K, Makin IRS, et al. Overview of Therapeutic Ultrasound Applications and Safety Considerations. J Ultras Med. 2012; 31: 623-34.
14. Suzuki R, Oda Y, Utoguchi N, Maruyama K. Progress in the development of ultrasound-mediated gene delivery systems utilizing nano-and microbubbles. J Control Release. 2011; 149: 36-41.
15. Ibsen S, Benchimol M, Simberg D, Schutt C, Steiner J, Esener S. A novel nested liposome drug delivery vehicle capable of ultrasound triggered release of its payload. J Control Release. 2011; 155: 358-66.
16. Ferrara KW, Borden MA, Zhang H. Lipid-Shelled Vehicles: Engineering for Ultrasound Molecular Imaging and Drug Delivery. Accounts of chemical research. 2009; 42: 881-92.
17. Krupka TM, Solorio L, Wilson RE, Wu HP, Azar N, Exner AA. Formulation and Characterization of Echogenic Lipid-Pluronic Nanobubbles. Mol Pharmaceut. 2010; 7: 49-59.
18. Marxer EEJ, Brussler J, Becker A, Schummelfeder J, Schubert R, Nimsky C, et al. Development and characterization of new nanoscaled ultrasound active lipid dispersions as contrast agents. Eur J Pharm Biopharm. 2011; 77: 430-7.
19. Yin TH, Wang P, Zheng RQ, Zheng BW, Cheng D, Zhang XL, et al. Nanobubbles for enhanced ultrasound imaging of tumors. Int J Nanomed. 2012; 7: 895-904.
20. Rapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst. 2007; 99: 1095-106.
21. Shiraishi K, Endoh R, Furuhata H, Nishihara M, Suzuki R, Maruyama K, et al. A facile preparation method of a PFC-containing nano-sized emulsion for theranostics of solid tumors. Int J Pharm. 2011; 421: 379-87.
22. Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma M.J. Nano-emulsions. curr opin colloid interface sci. 2004; 10: 102-110.
23. Jian J, Liu C, Gong Y, Su L, Zhang B, Wang Z, et al. India ink incorporated multifunctional phase-transition nanodroplets for photoacoustic/ultrasound dual-modality imaging and photoacoustic effect based tumor therapy. Theranostics. 2014; 4: 1026-38.
24. Javadi M, Pitt WG, Tracy CM, Barrow JR, Willardson BM, Hartley JM, Tsosie NH. Ultrasonic gene and drug delivery using eLiposomes. J Control Release. 2013; 167: 92-100.
25. Javadi M, Pitt WG, Belnap DM, Tsosie NH, Hartley JM. Encapsulating nanoemulsions inside eLiposomes for ultrasonic drug delivery. Langmuir. 2012; 28: 14720-9.
26. Min HS, Son S, Lee TW, Koo H, Yoon HY, Na JH, et al. Liver-Specific and Echogenic Hyaluronic Acid Nanoparticles Facilitating Liver Cancer Discrimination. Adv Funct Mater. 2013; 23: 5518-29.
27. Kim JH, Kim YS, Park K, Lee S, Nam HY, Min KH, et al. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release. 2008; 127: 41-9.
28. Lee SJ, Park K, Oh YK, Kwon SH, Her S, Kim IS, et al. Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice. Biomaterials. 2009; 30: 2929-39.
29. Lee SJ, Koo H, Jeong H, Huh MS, Choi Y, Jeong SY, et al. Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy. J Control Release. 2011; 152: 21-9.
30. Yoon HY, Son S, Lee SJ, You DG, Yhee JY, Park JH, et al. Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA. Sci Rep-Uk. 2014; 4.
31. Son S, Min HS, You DG, Kim BS, Kwon IC. Echogenic nanoparticles for ultrasound technologies: Evolution from diagnostic imaging modality to multimodal theranostic agent. Nano Today. 2014; 9: 525-40.
32. Carson AR, McTiernan CF, Lavery L, Grata M, Leng XP, Wang JJ, et al. Ultrasound-Targeted Microbubble Destruction to Deliver siRNA Cancer Therapy. Cancer Res. 2012; 72: 6191-9.
33. Liu HL, Fan CH, Ting CY, Yeh CK. Combining Microbubbles and Ultrasound for Drug Delivery to Brain Tumors: Current Progress and Overview. Theranostics. 2014; 4: 432-44.
34. Kim JH, Kim YS, Kim S, Park JH, Kim K, Choi K, et al. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel (Reprinted from Journal of Controlled Release, vol 109, pg 1, 2005). J Control Release. 2006; 111: 228-34.